Nanobiotix to Participate in the Jefferies London Healthcare Conference
Biotechnology company Nanobiotix will take part in a discussion at the Jefferies London Healthcare Conference, according to a company announcement.
Event Details
Nanobiotix has announced its participation in the Jefferies London Healthcare Conference scheduled for Monday, November 17, 2025. The session is set for 3:00 PM GMT (4:00 PM CET / 10:00 AM ET) and will take place in London, United Kingdom. Laurent Levy, co-founder of Nanobiotix and Chairman of the Executive Board, along with Bart van Rhijn, CFO and Head of Business Development, will represent the company.
Live Broadcast and Replay
The discussion will be broadcast live on the events page of the Investor Relations section of Nanobiotix's website. A replay will also be available following the event, allowing interested parties to view the presentation at a later time.
Company Background
Founded in 2003, Nanobiotix is a biotechnology company focused on the development of innovative nanoparticle-based treatments for cancer patients and other conditions. It has been listed on Euronext Paris since 2012 and on the Nasdaq Global Select Market since December 2020. The company has several subsidiaries, including one in Cambridge, Massachusetts, and owns over 25 patent families.
